Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

Clinical trial NCT05745623 · RECRUITING

Trial details

NCT number: NCT05745623
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Harboring NTRK Fusion Primary Central Nervous System Tumors Harboring NTRK Fusion

Start date: 2022-12-27
Primary completion: 2027-12-25
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.